HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of argon green vs krypton red laser for photocoagulation of subfoveal choroidal neovascularization in the macular photocoagulation study. Macular Photocoagulation Study (MPS) Group.

AbstractOBJECTIVE:
To evaluate the risks and benefits of argon-green compared with krypton red laser photocoagulation in the treatment of subfoveal choroidal neovascularization (CNV).
DESIGN:
Prospective randomized clinical trial assessing efficacy of laser treatment vs no treatment in the course of subfoveal CNV. Patients randomly assigned to laser treatment were randomly allocated to either argon green or krypton red laser photocoagulation. Scheduled follow-up for periods up to 5 years was performed.
SETTING:
Tertiary retinal referral centers.
PATIENTS:
Individuals with age-related macular degeneration and new subfoveal CNV or recurrent subfoveal CNV enrolled in the Foveal Photocoagulation Studies of the Macular Photocoagulation Study.
MAIN OUTCOME MEASURES:
Visual acuity, contrast sensitivity, reading spread, persistent and/or recurrent CNV, and treatment complications.
RESULTS:
There was no significant difference in average loss of visual acuity or contrast sensitivity from baseline levels in eyes treated with either wavelength. From baseline, eyes treated with argon green laser in the Subfoveal Recurrent CNV Study lost an average of 12 words per minute less than eyes treated with krypton red laser. Comparable rates of persistent and recurrent CNV were observed in the two laser treatment groups. Focal retinal vascular narrowing was more common in eyes treated with argon green laser.
CONCLUSIONS:
Small differences in outcomes favored argon-green treatment of subfoveal CNV, but the only statistically significant difference observed between green- and red-laser treatments was a smaller loss of reading speed among argon green-treated eyes in the Recurrent CNV Study. The multiple analyses performed in these two Macular Photocoagulation Study trials failed to identify any consistent clinically and statistically significant differences between green- or red-laser treatment in the management of eyes with subfoveal CNV.
Authors
JournalArchives of ophthalmology (Chicago, Ill. : 1960) (Arch Ophthalmol) Vol. 112 Issue 9 Pg. 1176-84 (Sep 1994) ISSN: 0003-9950 [Print] United States
PMID7522004 (Publication Type: Clinical Trial, Comparative Study, Journal Article, Randomized Controlled Trial, Research Support, U.S. Gov't, P.H.S.)
Topics
  • Aged
  • Aged, 80 and over
  • Choroid (blood supply, surgery)
  • Contrast Sensitivity
  • Female
  • Follow-Up Studies
  • Fovea Centralis (surgery)
  • Fundus Oculi
  • Humans
  • Laser Coagulation (methods)
  • Macular Degeneration (complications)
  • Male
  • Middle Aged
  • Neovascularization, Pathologic (etiology, surgery)
  • Postoperative Complications
  • Prospective Studies
  • Reading
  • Treatment Outcome
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: